Table 3 Association of IL-1β expression and clinicopathological variables
Number of patients | IL-1β high expression (%) | IL-1β low expression (%) | P- value (χ2 test) | |
|---|---|---|---|---|
Ovarian cancer (stage 1+2) | 96 | 31 (32.2) | 65 (67.8) | |
Age (years) | ||||
< 50 | 45 | 12 (26.7) | 31 (73.2) | |
> 51 | 51 | 19 (37.2) | 34 (62.8) | 0.471 |
Histological type | ||||
Serous | 25 | 5 (20.0) | 20 (80) | |
Mucinous | 24 | 9 (37.5) | 15 (62.5) | |
Endometroid | 26 | 8 (30.7) | 18 (69.3) | |
Clear cell | 21 | 9 (42.8) | 12 (57.1) | 0.372 |
Ascites | ||||
Negative | 52 | 15 (28.8) | 37 (71.2) | |
Positive | 54 | 16 (36.7) | 28 (63.2) | 0.432 |